Women's Health

If it’s not immediately obvious to you what leadership skills female pharmacists share with Apache helicopter pilots, you probably haven’t been working in pharmacy for very long.

The latest recommendation from the United States Preventive Services Task Force said cervical cancer screening depends on a woman’s age and other factors.

The FDA has approved a combined hormonal contraceptive for women that is the first vaginal ring contraceptive that can be used for an entire year.

The FDA has permitted marketing of Natural Cycles, the first mobile medical app that can be used as a method of contraception to prevent pregnancy.

Few young women develop venous thromboembolism, but 2 circumstances increase risk in women of childbearing age: pregnancy, and the use of sex hormones, including oral contraceptives.

Clinicians generally have 2 options for women who develop endometriosis: surgery or medical therapies. The goal is to address active symptoms, prevent recurrence, and control pain.

Survey authors identified an unmet need for clinician engagement regarding financial concerns after breast cancer diagnosis.

The FDA is warning consumers against serious risks of some ‘vaginal rejuvenation’ devices, and a lack of evidence to support their uses for this purpose.

The FDA has approved AbbVie's elagolix (Orilissa) product, a drug specifically developed for women with moderate to severe endometriosis pain.

Data collected from a number of patient safety reporting programs indicate that between 2% and 35% of prescription errors are linked to look alike, sound alike drug name similarities.

In general, infertility is described as an inability to conceive despite having frequent, unprotected intercourse for a year or more.

Officials with the FDA have granted accelerated approval to pembrolizumab (Keytruda, Merck) for 2 new indications, including the treatment of refractory primary mediastinal large B-cell lymphoma (PMBCL), and recurrent metastatic cervical cancer in previously treated patients whose tumors express PD-L1.

TherapeuticsMD announced it has received FDA approval for IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Health care providers should be aware of how HIV symptoms may affect menopausal women.

More research needed to determine if ADHD medication is safe to take before and during pregnancy.

Behind the scenes with Dr. Suzanne Soliman, who created National Women Pharmacist Day

Currently, more women practice in pharmacy than men, and it is expected that the number of women practicing will continue to rise.

Women in Specialty Pharmacy Lunch brings together leaders from various aspects of the specialty landscape.

Peripheral resistance was a major factor in high systolic blood pressure in men but not in women.

The first of a 2-part series on the influential women shaping the specialty pharmacy industry.

Women who have no signs or symptoms of ovarian cancer should not receive a screening, according to a draft recommendation statement from the US Preventive Services Task Force (USPSTF).

Although current guidelines indicate that women at average risk do not need to be screened for cervical cancer after age 65, the results of a recent study suggest that women up to age 85 can benefit from these screenings.

New research indicates that high consumption of certain dairy products may either increase or decrease the risk of developing breast cancer, depending on the food.

Published data seem to support OTC access.

A recently published study finds that maternal folic acid levels could have an effect on a child’s blood pressure.

Cardinal Health was again recognized among the nation's best workplaces for female advancement as a Top Company for Executive Women by the National Association for Female Executives.

Genetics that determine physical traits may play a large role in prevalence of conditions such as multiple sclerosis, autism, and diabetes.

African American women account for 62% of women diagnosed with HIV.

CVS Health has announced a major commitment in support of women's heart health, pledging to raise a minimum of $10 million over the next 3 years to support life-saving cardiovascular research and education.